KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-Current Debt (2016 - 2023)

Exact Sciences has reported Non-Current Debt over the past 14 years, most recently at $50.0 million for Q1 2023.

  • Quarterly Non-Current Debt changed N/A to $50.0 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $50.0 million through Mar 2023, changed N/A year-over-year, with the annual reading at $50.0 million for FY2022, N/A changed from the prior year.
  • Non-Current Debt was $50.0 million for Q1 2023 at Exact Sciences, roughly flat from $50.0 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $50.0 million in Q2 2022 and troughed at $21.4 million in Q3 2021.
  • The 5-year median for Non-Current Debt is $24.0 million (2019), against an average of $31.3 million.
  • Year-over-year, Non-Current Debt skyrocketed 2682.35% in 2019 and then fell 7.03% in 2020.
  • A 5-year view of Non-Current Debt shows it stood at $24.0 million in 2019, then dropped by 7.03% to $22.3 million in 2020, then fell by 4.05% to $21.4 million in 2021, then soared by 133.23% to $50.0 million in 2022, then changed by 0.0% to $50.0 million in 2023.
  • Per Business Quant, the three most recent readings for EXAS's Non-Current Debt are $50.0 million (Q1 2023), $50.0 million (Q4 2022), and $50.0 million (Q3 2022).